ChemicalsSmall capRs 3,662 crRs 10.0 cr traded a day
Close on 2026-08-21
2,081.60
−1.28%
52-week range32% of the way up
1,798.002,684.70
Market cap
3,662 cr
P/E (TTM)
13.3×
industry 36×
EPS (TTM)
156.80
Revenue YoY
+44.7%
Q1 FY27
Profit YoY
+126.0%
Net margin
13.7%
+4.9pt vs a year ago
Growth trend
+6.7pt
vs last quarter’s YoY
1 month
-14.4%
Below 52w high
29.0%
RSI (14)
2
oversold
Daily swing
3.9%
average true range
Volume
0.5×
vs 20-day average
Traded
Rs 10 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
1 week
−4.68%
1 month
−14.44%
3 months
−9.76%
6 months
+8.37%
1 year
−21.10%
The read
written from the numbers on this page
The evidence is mixed3 supporting, 3 against, 2 worth knowing
Supporting
revenue grew 45% year on year in the quarter ending 2026-06-30
net margin has widened from 6.9% to 13.7% across four quarters
priced at 13× earnings against an industry median of 36× — 63% below its peers
Against
trading 1% below its 200-day average
down 21% over twelve months
1 of the scans it matches has historically underperformed the market
Worth knowing
RSI at 2 is washed out — historically the better half of this site's measured edge comes from exactly this condition
the 8 scans it matches come from only 2 families — one signal wearing several hats rather than several signals
What would change this read: a close back above 2,112, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
read from the filings, with the figure behind every line
Working3
Revenue +54.8% year on year, Rs 653 cr to Rs 1,011 cr.
+54.8%Rs 653 crRs 1,011 cr
Net profit +97.3% year on year, Rs 70 cr to Rs 138 cr.
+97.3%Rs 70 crRs 138 cr
Profit grew faster than revenue, +97.3% against +54.8%.
+97.3%+54.8%
Needs watching
Nothing in the filings stands out either way.
Every figure here is computed from the company’s own filings. The wording is generated directly from the figures.
How it has performed
price return over each window, measured against zero
What the scans say today
8 of 47 matched on 2026-08-21
STYRENIX matches 8 of the 47 scans today, across 2 different kinds of evidence. Note how few kinds of evidence that is: several scans in one family are one signal wearing several hats, not several signals.
Return on capital uses profit before tax over equity plus borrowings. The textbook version adds finance costs back; those are not tagged reliably in quarterly filings, so this understates the ratio for a heavily borrowed company rather than flattering it. Balance sheets are filed half-yearly, so these can be up to six months behind the profit figures above.
Valuation against its own history
500 sessions since 2024-09-06
15×
median 20×
25×
now 13×
STYRENIX trades at 13× trailing earnings, below its median of 20× over this window — 34% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Analyst call filings were typically +0.14pt vs the market over the next 5 sessions (n=3,352) · AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362) · Results filings were typically -0.52pt vs the market over the next 5 sessions (n=7,520)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 45% against the same quarter a year earlier
profit rose 126% year on year
net margin widened from 8.9% to 13.7%
revenue rose in 3 of the last 4 quarters
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · consolidated
1,011
189
138
78.64
13.7%
Q4 FY26
2026-03-31 · consolidated
826
93
73
41.79
8.9%
Q3 FY26
2025-12-31 · consolidated
869
6
16
9.29
1.9%
Q3 FY25
2024-12-31 · consolidated
691
64
48
27.12
6.9%
Q2 FY25
2024-09-30 · consolidated
653
94
70
39.86
10.7%
Q1 FY25
2024-06-30 · standalone
699
82
61
34.80
8.8%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-9.7%
Versus 200-day average-1.4%
Below 52-week high-22.5%
Above 52-week low+15.8%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)2.1
Higher closes in last 50 of 5
Six-month return+8.37%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)3.94%
Volume versus 20-day0.5x
Median daily turnoverRs 10.0 cr
Peers
Chemicals · 44 classified companies
STYRENIX trades at 13.3× trailing earnings against an industry median of 36.0× across 41 other classified companies in its industry — cheaper than them, by 63%. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.
Session
Scans
Which
2026-08-21
1
Growing fast, sold off anyway
2026-08-18
2
Uptrend taking a breather, Oversold, but trend intact